azd2563 has been researched along with Staphylococcal Infections in 3 studies
*Staphylococcal Infections: Infections with bacteria of the genus STAPHYLOCOCCUS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acton, DG; Betts, MJ; Dennis, M; Gravestock, MB; Hatter, G; McGregor, A; Swain, ML; Wilson, RG; Woods, L; Wookey, A | 1 |
| Anderegg, TR; Biedenbach, DJ; Jones, RN | 1 |
| Bowker, KE; Howe, RA; MacGowan, AP; Noel, AR; Walsh, TR; Wootton, M | 1 |
3 other study(ies) available for azd2563 and Staphylococcal Infections
| Article | Year |
|---|---|
New classes of antibacterial oxazolidinones with C-5, methylene O-linked heterocyclic side chains.
Topics: Animals; Anti-Bacterial Agents; Gram-Positive Bacteria; Heterocyclic Compounds; Hydrocarbons; Methane; Mice; Microbial Sensitivity Tests; Oxazolidinones; Rats; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship | 2003 |
In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolates.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Humans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus | 2002 |
Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance | 2003 |